Challenger Limited has announced the full redemption of its Challenger Capital Notes 3 (ASX: CGFPC) on 25 May 2026 at face value of A$100 per note. This redemption has received approval from the Australian Prudential Regulation Authority (APRA), marking a significant capital management decision for the investment management and life insurance firm. All outstanding CCN3 notes will be redeemed in cash, providing holders with a clear exit at par value.
For investors holding CCN3 notes, the redemption represents both a return of capital and the end of the income stream from this instrument. Alongside the full redemption, Challenger will pay a final distribution of A$1.47 per note on the same date, covering the period from 25 February 2026 to 25 May 2026. This final distribution is contingent on no payment conditions existing on the redemption date, a standard provision in capital note terms. The record date for the final distribution is set for 15 May 2026, meaning investors must hold the notes on that date to receive the final payment.
The timing of this redemption is noteworthy. With the last day of trading in CCN3 notes on the ASX expected to be 13 May 2026, investors have a limited window to decide whether to hold until redemption or exit before the final trading day. The redemption price of par value means there is no capital gain or loss for investors who hold to maturity, contrasting with the potential volatility that might occur in the secondary market following this announcement. The final distribution yield of approximately 5.88 percent annualised on the A$100 face value for the three-month period adds a modest return component for those holding through to redemption.
Challenger’s decision to redeem these notes, approved by APRA, reflects the company’s capital management strategy and current financial position. However, the company has explicitly noted that this redemption does not indicate any intention to redeem other outstanding capital instruments and that any future redemptions would require separate APRA approval. This clarification is important context for holders of other Challenger capital notes, suggesting the company is making targeted redemption decisions rather than signaling a broad capital restructuring.
Investors should consider their reinvestment options ahead of the May redemption, particularly in the current interest rate environment. The redemption provides certainty regarding capital return but removes ongoing distributions from this particular security. Those seeking continued income exposure may need to deploy capital elsewhere once the notes are redeemed. The announcement is price sensitive and has been flagged as material by the ASX.
View the full ASX announcement (PDF)
About Challenger Limited (ASX: CGF)
Challenger Limited is an investment management company focused on providing financial services related to retirement and annuities. The company operates two main segments: Life, which provides annuity and retirement income products in Australia and Japan, and Funds Management, which manages boutique investment funds. The company is headquartered in Sydney, Australia and also operates in Asia and the United Kingdom.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
